Showing results (2301-2310 of 2,572) with videos related to
Sort By:
Pageof 258
BMJ (Clinical Research Ed.)|January 28, 2006
Trends in sexually transmitted infections in general practice 1990-2000: population based study using data from the UK general practice research databaseJackie A Cassell, Catherine H Mercer, Lorna Sutcliffe, et al.Cells|April 13, 2023
An Efficient Humanized Mouse Model for Oral Anti-Retroviral AdministrationAmber K Virdi, Sang Ho, Melanie S Seaton, et al.American Journal of Medical Genetics. Part A|July 3, 2007
Meckel syndrome in the Hutterite population is actually a Joubert-related cerebello-oculo-renal syndromeKym M Boycott, Jillian S Parboosingh, James N Scott, et al.Circulation|December 7, 2021
Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced CardiotoxicityTarek Magdy, Mariam Jouni, Hui-Hsuan Kuo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2012
Safety, pharmacokinetic, and pharmacodynamic phase I dose-escalation trial of PF-00562271, an inhibitor of focal adhesion kinase, in advanced solid tumorsJeffrey R Infante, D Ross Camidge, Linda R Mileshkin, et al.Health Technology Assessment (Winchester, England)|August 29, 2009
Rehabilitation of older patients: day hospital compared with rehabilitation at home. A randomised controlled trialS G Parker, P Oliver, M Pennington, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancerPuneeth Iyengar, Brian D Kavanagh, Zabi Wardak, et al.Clinical Lung Cancer|May 28, 2026
High Programmed Death-Ligand 1 Expression is Associated With a Shorter Progression Free Survival in ALK-Rearranged Lung Cancer Patients Treated With First Line Tyrosine Kinase InhibitorsYunan Nie, Alyse Staley, Trista K Hinz, et al.Science Signaling|January 29, 2015
Phosphorylation of FADD by the kinase CK1α promotes KRASG12D-induced lung cancerBrittany M Bowman, Katrina A Sebolt, Benjamin A Hoff, et al.International Journal of Cancer|March 31, 2011
MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migrationShilpi Arora, Aarati R Ranade, Nhan L Tran, et al.Pageof 258